Pandha HS - Search Results

1

Immunotherapy of murine prostate cancer using whole tumour cells killed ex vivo by cytosine deaminase/5-fluorocytosine suicide-gene therapy.

Pandha HS, Cook D, Greenhalgh R, Dalgleish A. Pandha HS, et al. BJU Int. 2005 Jun;95(9):1336-43. doi: 10.1111/j.1464-410X.2005.05528.x. BJU Int. 2005. PMID: 15892827

2

Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study.

Pandha HS, John RJ, Hutchinson J, James N, Whelan M, Corbishley C, Dalgleish AG. Pandha HS, et al. BJU Int. 2004 Aug;94(3):412-8. doi: 10.1111/j.1464-410X.2004.04922.x. BJU Int. 2004. PMID: 15291878 Clinical Trial.

3

Immunotherapy of murine prostate cancer using whole tumor cells killed ex vivo by herpes simplex viral thymidine kinase/ganciclovir suicide gene therapy.

Pandha H, Eaton J, Greenhalgh R, Soars D, Dalgleish A. Pandha H, et al. Cancer Gene Ther. 2005 Jun;12(6):572-8. doi: 10.1038/sj.cgt.7700836. Cancer Gene Ther. 2005. PMID: 15803141

4

Advances in prostate cancer immunotherapy.

Havranek EG, Whelan MA, Greenhalgh R, Dalgleish AG, Pandha H. Havranek EG, et al. Surg Oncol. 2002 Jun;11(1-2):35-45. doi: 10.1016/s0960-7404(02)00012-9. Surg Oncol. 2002. PMID: 12031866 Review.

5

Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity.

Todryk SM, Eaton J, Birchall L, Greenhalgh R, Soars D, Dalgleish AG, Melcher AA, Pandha HS. Todryk SM, et al. Among authors: pandha hs. Cancer Immunol Immunother. 2004 Apr;53(4):323-30. doi: 10.1007/s00262-003-0452-1. Epub 2003 Nov 28. Cancer Immunol Immunother. 2004. PMID: 14648067 Free PMC article.

6

Immunotherapeutic potential of whole tumour cells.

Ward S, Casey D, Labarthe MC, Whelan M, Dalgleish A, Pandha H, Todryk S. Ward S, et al. Cancer Immunol Immunother. 2002 Sep;51(7):351-7. doi: 10.1007/s00262-002-0286-2. Epub 2002 Jun 14. Cancer Immunol Immunother. 2002. PMID: 12192534 Free PMC article. Review.

7

Tumor antigens as surrogate markers and targets for therapy and vaccines.

Dalgleish A, Pandha H. Dalgleish A, et al. Adv Cancer Res. 2007;96:175-90. doi: 10.1016/S0065-230X(06)96009-6. Adv Cancer Res. 2007. PMID: 17161680 Review.

8

Oncological applications of gene therapy.

Pandha HS, Martin LA, Rigg AS, Ross P, Dalgleish AG. Pandha HS, et al. Curr Opin Investig Drugs. 2000 Sep;1(1):122-34. Curr Opin Investig Drugs. 2000. PMID: 11249588 Review.

9

Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies.

Pandha HS, Stockwin LH, Eaton J, Clarke IA, Dalgleish AG, Todryk SM, Blair GE. Pandha HS, et al. Prostate Cancer Prostatic Dis. 2003;6(1):6-11. doi: 10.1038/sj.pcan.4500611. Prostate Cancer Prostatic Dis. 2003. PMID: 12664058

10

Cryopreservation of immature monocyte-derived dendritic cells results in enhanced cell maturation but reduced endocytic activity and efficiency of adenoviral transduction.

John J, Hutchinson J, Dalgleish A, Pandha H. John J, et al. J Immunol Methods. 2003 Jan 15;272(1-2):35-48. doi: 10.1016/s0022-1759(02)00430-1. J Immunol Methods. 2003. PMID: 12505710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters